跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 偉仁
助理教授
,
公共衛生學科
https://orcid.org/0000-0003-0683-7904
電子郵件
wjchen
tmu.edu
tw
h-index
458
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2024
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(34)
類似的個人檔案
(6)
指紋
查看啟用 Wei-Jen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Genotyping
84%
Methylation
66%
Gene Polymorphism
45%
Blood Lead Level
42%
Selenium Blood Level
34%
Folic Acid Blood Level
33%
Eicosanoid Receptor
33%
DNA Methylation
33%
Binding Domain
33%
XRCC1
33%
Haplotype
28%
High-Performance Liquid Chromatography
26%
Genetic Polymorphism
23%
Cyanocobalamin
22%
Vitamin Blood Level
22%
Methyltransferase
18%
Atomic Absorption Spectroscopy
18%
Deoxycytidine
17%
Aldosterone Synthase
16%
DNMT1
16%
DNA Methyltransferase
16%
Vascular Endothelial Growth Factor A
16%
Alpha Oxidation
16%
Metabotropic Receptor
16%
Insulin-Like Growth Factor-Binding Protein
16%
Bone Density
16%
Metabolic Pathway
16%
Osteolysis
16%
X Ray
16%
Glutamic Acid
16%
Overall Survival
16%
Renin Angiotensin Aldosterone System
16%
AS3MT
16%
Adiponectin
16%
Immunoglobulin E
16%
Serotonin
16%
Dose Response
15%
Case-Control Study
14%
DNMT3A
13%
Glomerulus Filtration
12%
Restriction Fragment Length Polymorphism
10%
Cacodylic Acid
9%
Single-Nucleotide Polymorphism
9%
Polymerase Chain Reaction
8%
Genetic Divergence
8%
Neurotransmitter
8%
Leukocyte Differential Count
8%
Eosinophil Count
8%
Blood Cell Count
8%
Comorbidity
8%
Medicine and Dentistry
Methylation
100%
Urinary System
46%
Transitional Cell Carcinoma
33%
Clear Cell Renal Cell Carcinoma
33%
Developmental Delay
33%
8 Hydroxydeoxyguanosine
33%
Medicine
33%
Fine Particulate Matter
33%
Particular Matter 2.5
33%
Odds Ratio
23%
Family Practice
19%
Methyltransferase
18%
Bladder Cancer
18%
Pediatrics
18%
Arginine
17%
Somatomedin Binding Protein 3
16%
Receptor Protein
16%
Insulin Resistance
16%
Adolescent
16%
8-Oxoguanine
16%
Preschooler
16%
Health Status
16%
4 Iodo 2,5 Dimethoxyamphetamine
16%
Synapsin II
16%
Study Subject
16%
DNA Glycosylase
16%
Chronic Kidney Disease
16%
Fetus Growth
16%
Medicare
16%
Clinical Guideline
16%
Cohort Analysis
16%
Hyperactivity
16%
Attention Deficit Disorder
16%
Haplotype
13%
Atomic Absorption Spectrometry
9%
Third Trimester Pregnancy
9%
Fetus Weight
9%
High-Performance Liquid Chromatography
9%
Cacodylic Acid
8%
Case-Control Study
7%
Impulsiveness
7%
DNA Repair
6%
Glutathione S-Transferase
6%
Purine Nucleoside Phosphorylase
6%
Genomic DNA
5%
Polymerase Chain Reaction
5%
Division
5%
Pharmacology, Toxicology and Pharmaceutical Science
Developmental Delay
83%
Bladder Cancer
52%
Renal Cell Carcinoma
50%
Transitional Cell Carcinoma
50%
Methyltransferase
35%
Synapsin II
33%
Chronic Kidney Failure
33%
Health Status
33%
Receptor Protein
33%
Case-Control Study
32%
High Performance Liquid Chromatography
22%
Cacodylic Acid
19%
DNA Glycosyltransferase
16%
Vasculotropin A
16%
Somatomedin Binding Protein 3
16%
DNA (Cytosine 5) Methyltransferase 1
16%
DNA Methyltransferase 3A
16%
Heavy Metal
16%
Folic Acid
16%
Recurrent Disease
16%
8 Hydroxyguanine
16%
8 Hydroxydeoxyguanosine
16%
Vitamin B12
16%
2,5-Dimethoxy-4-iodoamphetamine
16%
Prostate Cancer
16%
Toxicological Sciences
16%
Hyperactivity
16%
Pregnancy Diabetes Mellitus
16%
Attention Deficit Disorder
16%
Methanearsonic Acid
13%
Arsenite
6%
Arginine
6%
Glutathione
6%
Transferase
6%
Purine Nucleoside Phosphorylase
6%
DNA Methyltransferase
5%
